Rubicon Research Private Limited: AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count
Recall reason: Discoloration. Recalled by Rubicon Research Private Limited. Distribution: Nationwide in the US. Classification (Class III — minor violation). Affected lots/NDC/dates: Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report